Researchers identified pharmacological markers that could refine oral PrEP dosing for men who have sex with men (MSM), according to work published in Nature Communications. The study focuses on the pharmacological mechanics behind how PrEP drugs distribute and act, aiming to support more precise oral regimens. Instead of treating adherence alone as the main variable, the reported approach dissects measurable markers that correspond to exposure and effect. (Pharmacological markers are measurable biological indicators used to assess whether a prevention regimen is reaching the right drug levels.) If validated in broader populations, the findings could influence how clinicians monitor effectiveness and how trials define biologically grounded dosing targets for oral PrEP.